Format
Sort by
Items per page

Send to

Choose Destination

Best matches for htlv-1 multiple sclerosis:

Search results

Items: 1 to 20 of 135

1.

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation.

Leal FE, Menezes SM, Costa EAS, Brailey PM, Gama L, Segurado AC, Kallas EG, Nixon DF, Dierckx T, Khouri R, Vercauteren J, Galvão-Castro B, Saraiva Raposo RA, Van Weyenbergh J.

Front Microbiol. 2018 May 22;9:985. doi: 10.3389/fmicb.2018.00985. eCollection 2018.

2.

The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Rotem E, Faingold O, Charni M, Klug YA, Harari D, Shmuel-Galia L, Nudelman A, Rotter V, Shai Y.

PLoS Pathog. 2018 May 4;14(5):e1007044. doi: 10.1371/journal.ppat.1007044. eCollection 2018 May.

3.

Immunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases.

Enose-Akahata Y, Azodi S, Smith BR, Billioux BJ, Vellucci A, Ngouth N, Tanaka Y, Ohayon J, Cortese I, Nath A, Jacobson S.

PLoS Pathog. 2018 Apr 30;14(4):e1007042. doi: 10.1371/journal.ppat.1007042. eCollection 2018 Apr.

4.

The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Saito M, Sejima H, Naito T, Ushirogawa H, Matsuzaki T, Matsuura E, Tanaka Y, Nakamura T, Takashima H.

Virol J. 2017 Dec 4;14(1):234. doi: 10.1186/s12985-017-0902-6.

5.

Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).

Azodi S, Nair G, Enose-Akahata Y, Charlip E, Vellucci A, Cortese I, Dwyer J, Billioux BJ, Thomas C, Ohayon J, Reich DS, Jacobson S.

Ann Neurol. 2017 Nov;82(5):719-728. doi: 10.1002/ana.25072. Epub 2017 Nov 8.

PMID:
29024167
6.

Retinal Nerve Fiber Layer Thickness in Human T-cell Lymphotropic Virus Type 1 Patients.

Merle H, Hage R, Jeannin S, Cabre P, Olindo S.

Curr Eye Res. 2017 Dec;42(12):1644-1649. doi: 10.1080/02713683.2017.1329443. Epub 2017 Oct 6.

PMID:
28985098
7.

Retroviral envelope proteins: Involvement in neuropathogenesis.

Hansen DT, Petersen T, Christensen T.

J Neurol Sci. 2017 Sep 15;380:151-163. doi: 10.1016/j.jns.2017.07.027. Epub 2017 Jul 22. Review.

PMID:
28870557
8.

A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation.

Menezes SM, Leal FE, Dierckx T, Khouri R, Decanine D, Silva-Santos G, Schnitman SV, Kruschewsky R, López G, Alvarez C, Talledo M, Gotuzzo E, Nixon DF, Vercauteren J, Brassat D, Liblau R, Vandamme AM, Galvão-Castro B, Van Weyenbergh J.

Front Immunol. 2017 Feb 14;8:97. doi: 10.3389/fimmu.2017.00097. eCollection 2017.

9.

The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region.

Afanasyeva MA, Putlyaeva LV, Demin DE, Kulakovskiy IV, Vorontsov IE, Fridman MV, Makeev VJ, Kuprash DV, Schwartz AM.

PLoS One. 2017 Feb 24;12(2):e0172681. doi: 10.1371/journal.pone.0172681. eCollection 2017.

10.

Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Salapa H.

J Neuroimmunol. 2017 Mar 15;304:56-62. doi: 10.1016/j.jneuroim.2016.07.005. Epub 2016 Jul 17. Review.

PMID:
27449854
11.

Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

AIDS Res Hum Retroviruses. 2015 Feb;31(2):242-9. doi: 10.1089/AID.2014.0171. Epub 2014 Nov 19.

PMID:
25295378
12.

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH, Fleisher TA, Turner M, Urquhart NE, Wharfe GH, Figg WD, Peer CJ, Goldman CK, Waldmann TA, Morris JC.

Clin Immunol. 2014 Dec;155(2):176-87. doi: 10.1016/j.clim.2014.09.012. Epub 2014 Sep 28.

13.

In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.

Liu W, Nair G, Vuolo L, Bakshi A, Massoud R, Reich DS, Jacobson S.

Ann Neurol. 2014 Sep;76(3):370-8. doi: 10.1002/ana.24213. Epub 2014 Jul 22.

14.

CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis.

Menezes SM, Decanine D, Brassat D, Khouri R, Schnitman SV, Kruschewsky R, López G, Alvarez C, Talledo M, Gotuzzo E, Vandamme AM, Galvão-Castro B, Liblau R, Weyenbergh JV.

J Neuroinflammation. 2014 Jan 29;11:18. doi: 10.1186/1742-2094-11-18.

15.

Tropical myelopathies.

Román GC.

Handb Clin Neurol. 2014;121:1521-48. doi: 10.1016/B978-0-7020-4088-7.00102-4. Review.

PMID:
24365434
16.

Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.

Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ.

Virol J. 2013 Dec 23;10:360. doi: 10.1186/1743-422X-10-360.

17.

Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Levin MC, Lee S, Gardner LA, Shin Y, Douglas JN, Cooper C.

J Clin Cell Immunol. 2013 Jun 30;4. doi: 10.4172/2155-9899.1000148.

18.

Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.

Jones RB, Leal FE, Hasenkrug AM, Segurado AC, Nixon DF, Ostrowski MA, Kallas EG.

J Negat Results Biomed. 2013 Jan 10;12:3. doi: 10.1186/1477-5751-12-3.

19.

Antibody transfection into neurons as a tool to study disease pathogenesis.

Douglas JN, Gardner LA, Lee S, Shin Y, Groover CJ, Levin MC.

J Vis Exp. 2012 Sep 26;(67). pii: 4154. doi: 10.3791/4154.

20.

Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

Moens B, Decanine D, Menezes SM, Khouri R, Silva-Santos G, Lopez G, Alvarez C, Talledo M, Gotuzzo E, de Almeida Kruschewsky R, Galvão-Castro B, Vandamme AM, Van Weyenbergh J.

PLoS Negl Trop Dis. 2012;6(7):e1729. doi: 10.1371/journal.pntd.0001729. Epub 2012 Jul 24.

Supplemental Content

Loading ...
Support Center